Correlates of breakthrough COVID-19 in vaccinated patients with systemic sclerosis: survival analysis from a multicentre international patient-reported survey (2024)
- Authors:
- Autor USP: SHINJO, SAMUEL KATSUYUKI - FM
- Unidade: FM
- DOI: 10.1007/s00296-023-05433-z
- Subjects: DOENÇAS AUTOIMUNES; COVID-19; QUESTIONÁRIOS
- Language: Inglês
- Imprenta:
- Publisher place: Heidelberg
- Date published: 2024
- Source:
- Título: Rheumatology international
- ISSN: 0172-8172
- Volume/Número/Paginação/Ano: v. 44, n. 1, p. 89-97, 2024
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
AHMED, Sakir et al. Correlates of breakthrough COVID-19 in vaccinated patients with systemic sclerosis: survival analysis from a multicentre international patient-reported survey. Rheumatology international, v. 44, n. 1, p. 89-97, 2024Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/76832. Acesso em: 14 fev. 2026. -
APA
Ahmed, S., Gupta, L., Kuwana, M., Pauling, J. D., Day, J., Ravichandran, N., et al. (2024). Correlates of breakthrough COVID-19 in vaccinated patients with systemic sclerosis: survival analysis from a multicentre international patient-reported survey. Rheumatology international, 44( 1), 89-97. doi:10.1007/s00296-023-05433-z -
NLM
Ahmed S, Gupta L, Kuwana M, Pauling JD, Day J, Ravichandran N, Joshi M, Parodis I, Sen P, Shinjo SK. Correlates of breakthrough COVID-19 in vaccinated patients with systemic sclerosis: survival analysis from a multicentre international patient-reported survey [Internet]. Rheumatology international. 2024 ; 44( 1): 89-97.[citado 2026 fev. 14 ] Available from: https://observatorio.fm.usp.br/handle/OPI/76832 -
Vancouver
Ahmed S, Gupta L, Kuwana M, Pauling JD, Day J, Ravichandran N, Joshi M, Parodis I, Sen P, Shinjo SK. Correlates of breakthrough COVID-19 in vaccinated patients with systemic sclerosis: survival analysis from a multicentre international patient-reported survey [Internet]. Rheumatology international. 2024 ; 44( 1): 89-97.[citado 2026 fev. 14 ] Available from: https://observatorio.fm.usp.br/handle/OPI/76832 - High prevalence of necrotizing myofibers in adult dermatomyositis muscle biopsies
- Rituximab as a treatment for human immunodeficiency virus-associated nemaline myopathy: What does the literature have to tell us?
- Clinical manifestations, outcomes, and antibody profile of Brazilian adult patients with dermatomyositis: a single-center longitudinal study
- Long-term effects of early pulse methylprednisolone and intravenous immunoglobulin in patients with dermatomyositis and polymyositis
- Vaccine hesitancy decreases in rheumatic diseases, long-term concerns remain in myositis: a comparative analysis of the COVAD surveys
- Type 1 diabetes, COVID-19 vaccines and short-term safety: Subgroup analysis from the global COVAD study
- Cardiovascular manifestations in idiopathic inflammatory myopathies
- Flares after COVID-19 infection in patients with idiopathic inflammatory myopathies: results from the COVAD study
- Vaccine hesitancy in patients with autoimmune diseases. [Carta]: data from the coronavirus disease-2019 vaccination in autoimmune diseases study
- Different clinical phenotypes in anti-melanoma differentiation-associated protein 5-associated positive dermatomyositis
Informações sobre o DOI: 10.1007/s00296-023-05433-z (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
